Age-related DNA methylation in paired normal and tumour breast tissue in Chinese breast cancer patients

Abstract

Age-related DNA methylation is a potential mechanism contributing to breast cancer development. Studies of primarily Caucasian women have identified many CpG sites of age-related methylation in non-diseased breast tissue possibly driving cancer development over time. There is a paucity of studies involving Asian women whose ages at breast cancer onset are usually younger than Caucasians. We identified the 181 most consistent age-related methylation events in non-diseased breast tissue across published studies. Age-related methylation events were measured in adjacent normal and breast tumour tissue in an exclusively Asian population at the previously identified age-related methylation sites. Age-related methylation was found in 118 probes in adjacent normal breast tissue. Methylation of 99% of these sites was increased with age and predominantly located on CpG islands in promoter regions. To ascertain biological relevance to breast cancer, we focused on the 37 sites with overall higher methylation in tumour compared to adjacent normal samples. Some sites positively related to age, including AQP5 and CORO6, inversely correlated with gene expression. Several others have known involvement in suppression of carcinogenesis including GPC5 and SST, suggesting that perturbation of epigenetic regulation at these sites due to ageing may contribute to the progression of carcinogenesis. This study highlights an age-related methylation landscape in non-tumour tissue, consistent not just across studies, but also across different populations. We present candidate age-related methylation sites warranting further investigation as potential epigenetic drivers of breast cancer. They may serve as potential targets of site-specific demethylation intervention strategies for the prevention of age-related breast cancer.

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1

“…MSC-2 featured more hypermethylation of AQP5 and ZNF304 than MSC-1. Interestingly, AQP5 is a potential epigenetic driver of tumor development (42). The other 11 ssMDGs, such as ADAM32, SLC35D3, and TMEM150C, were specific for MSC-1.…”

Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

“…Oncoprint analysis revealed genetic alterations in FABP4 (14%), ADIPOQ (2.9%), PPARG (2.8%), PPARGC1A (1.5%), CD36 (1.7%), and CREBBP (11%) in patients with breast cancer in a TCGA study. DNA methylation is an epigenetic alteration that is involved in breast cancer progression [ 32 ]. Methylation of the CpG island gene is known to predict breast cancer progression [ 33 ].…”

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma

“…Studies have shown that CORO6 is a potential tumor suppressor in renal cancer (Morris et al, 2011). Kiely et al (2020) found that low CORO6 expression was associated with poorer overall breast cancer survival. RNF175 and RNF213 share their E3 ubiquitin ligase activity and play an important role in protein post-translational ubiquitination modification (Kaneko et al, 2016).…”